Expedition TherapeuticsListed
expeditiontx.combiotech_life_sciences
Expedition Therapeutics is a biotech company developing treatments for inflammatory and respiratory diseases, including COPD. The company's lead drug, EXPD-101, targets neutrophil…
Portfolio
A closer look at the companies associated with this firm. Verified team members can update the portfolio after signing in.
This is the portfolio currently shown on the public firm page.
Expedition Therapeutics is a biotech company developing treatments for inflammatory and respiratory diseases, including COPD. The company's lead drug, EXPD-101, targets neutrophil…
Vera Therapeutics is focused on transforming medicine in autoimmune diseases, particularly IgA nephropathy, through rigorous scientific research and patient-centered approaches.
Advancing novel antidepressants and anxiolytics based on clinically validated mechanisms powered by our Glyph™ platform.
Atsena Therapeutics is a clinical-stage gene therapy company developing first- and best-in-class treatments for inherited retinal diseases, including X-linked retinoschisis and Le…
ArriVent BioPharma is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unm…
BioAge Labs is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging.
RayzeBio is focused on creating precision radiopharmaceutical therapies (RPTs) that transform people’s lives. With an innovation-leading position in actinium-based RPTs and a pipe…
Karuna Therapeutics is focused on developing first-in-class therapeutics for central nervous system disorders, particularly schizophrenia and Alzheimer's disease. Their lead produ…
Natera is a global leader in cell-free DNA testing, providing advanced genetic testing solutions across various healthcare domains including oncology, organ health, women's health…
Capstan Therapeutics is focused on in vivo engineering of cells through targeted lipid nanoparticles, aiming to address complex health issues and enhance people's lives.
Avenzo Therapeutics is committed to improving the lives of cancer patients by developing next-generation oncology therapies that address high unmet medical needs.
Marea Therapeutics is focused on developing next-generation medicines for cardioendocrine diseases by leveraging large-scale human genetic data and advancements in biology.
Axonis Therapeutics is a Boston-based, neuro-focused biotechnology company developing first- and best-in-class medicines targeting KCC2, the critical mediator of inhibitory neurot…
Alkeus Pharmaceuticals is dedicated to developing novel treatments for degenerative retinal diseases, focusing on conditions like Stargardt disease and geographic atrophy. Their u…
Rapport Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery and development of precision small molecule medicines for central nervous system (CNS)…
At Aiolos Bio, we are dedicated to revolutionizing the treatment landscape for respiratory disease and other immunological disorders. Our goal is to provide patients and caregiver…
Claris Bio is a late-stage therapeutics company dedicated to advancing transformative therapies for sight-threatening conditions where no or limited treatment options exist.
City Therapeutics is a biopharmaceutical company harnessing next-generation engineering of RNAi trigger molecules to improve and expand the reach of RNAi-based medicines. The comp…
Coultreon Biopharma is focused on developing life-changing medicines for patients affected by chronic inflammatory diseases, leveraging expertise in immunology and drug discovery…
ARTBIO is redefining cancer care by developing a new class of alpha radioligand therapies (ART) and building the ecosystem that maximizes their potential.